Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Clinical-Microbiomics A/S
A/S
Active
Reklamebeskyttelse
CVR 37230634
Fruebjergvej 3, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 10 years old
30 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Clinical-Microbiomics A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AC
Anders Christian Neto de Sousa Grøn
Chief Executive Officer
Chief Executive Officer
2021
Former (3)
RV
Rasmus Vendler Toft-Kehler
Management
Management
2015 – 2016
LM
Lone Merete Veng
Chief Executive Officer
Chief Executive Officer
2016 – 2016
MA
Martin Andreas Santini
Chief Executive Officer
Chief Executive Officer
2016 – 2021
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (6)
NA
Nathan Allen Ledeboer
Board of Directors
Board of Directors
2023
BH
Bruce Harvey Grant
Board of Directors
Board of Directors
2023
IV
Isabelle Valerie de Cremoux
Board of Directors
Board of Directors
2022
MN
Manoj Nirmal Dadlani
Chairman
Chairman
2023
CP
Caroline Popper
Board of Directors
Board of Directors
2023
MO
Morten Otto Alexander Sommer
Board of Directors
Board of Directors
2023
Former (6)
TT
Torben Thomasen
Board of Directors
Board of Directors
2022 – 2023
OS
Ole Skov
Chairman
Chairman
2015 – 2017
HD
Henrik Dalbøge
Board of Directors
Board of Directors
2016 – 2023
TA
Thomas Alsbjerg
Board of Directors
Board of Directors
2021 – 2023
DL
Dennis Landbo Nielsen
Board of Directors
Board of Directors
2015 – 2021
MA
Morten Asser Karsdal
Board of Directors
Board of Directors
2019 – 2021
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Applied Industries Holding AB
Individual
33.33–49.99%
33.33–49.99%
2023
MANJIN ApS
Company
5–9.99%
5–9.99%
2023
VENDLER ApS
Company
5–9.99%
5–9.99%
2023
Health For Life Capital II FPCI – Alpha Compartment
Individual
5–9.99%
5–9.99%
2024
Health For Life Capital II Prima S.C.A. RAIF
Individual
5–9.99%
5–9.99%
2024
Health for Life Capital II FPCI - ALPHA Compartment
Individual
5–9.99%
5–9.99%
2022
OD Clinical Holding ApS
Company
33.33–49.99%
33.33–49.99%
2016
TLC HOLDING ApS
Company
5–9.99%
5–9.99%
2022
Clinical-Microbiomics A/S
Company
10–14.99%
10–14.99%
2016
TAL Invest ApS
Company
5–9.99%
5–9.99%
2022
REINHOLDT ENGINEERING ApS
Company
5–9.99%
5–9.99%
2022
Verde Family Holding ApS
Company
5–9.99%
5–9.99%
2022
ADSIDIUS ApS
Company
5–9.99%
5–9.99%
2023
BIRKEHEGNET 13 HOLDING ApS
Company
5–9.99%
5–9.99%
2022
DACCO INVEST ApS
Company
5–9.99%
5–9.99%
2022
Pinnacle Holding ApS
Company
15–19.99%
15–19.99%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Clinical-Microbiomics A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network